ArticleFrontiers in nutrition2026
Assessing the ability of bovine mesenchymal stem cells to grow on okara-based scaffolds derived from soy milk waste.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary mesenchymal stem cells used in cultured meat production are anchorage-dependent, and therefore require a solid substrate for attachment and proliferation. However, widely used commercial microcarriers are typically composed of synthetic polymers, creating a significant bottleneck as they require complex and costly cell-detachment processes prior to consumption. This study investigated the repurposing of okara, a by-product of soy milk and tofu production, into microcarriers for the cultivation of adipose-derived bovine mesenchymal stem cells (AD-bMSCs). We developed and characterized multiple soy-based scaffold variants by subjecting the raw material to treatments ranging from high homogenization and plasma exposure to simple freeze-drying and wet application. Comparative analysis revealed that complex processing did not improve cell performance. Instead, the minimally processed wet okara variant emerged as the most promising candidate, streamlining production by eliminating the need for drying and pre-soaking steps. In preliminary larger-volume experiments, OP-M showed promising support for AD-bMSC growth under static conditions, with performance comparable to that of commercial microcarrier controls, from day 17 onward. Cells expanded on these soy microcarriers retained their ability to proliferate, and maintained high expression of the mesenchymal surface markers CD44 and CD29. Furthermore, cell functionality was demonstrated by successful lipid accumulation following detachment from scaffolds, at levels comparable to those observed under 2D control conditions. These findings suggest that agricultural waste can be valorized into a high-value, edible bio-scaffold that supports stem cell expansion without compromising cellular characteristics. Okara-derived microcarriers hold the potential to provide a scalable and sustainable alternative to existing microcarrier systems in cultured meat production, although further research is needed to establish and optimize this platform.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.